Breakthrough Streptococcus pneumoniae meningitis during clarithromycin therapy for acute otitis media.
Bochud
P Y
PY
Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. Pierre-Yves.Bochud@chuv.hospvd.ch
Calandra
T
T
Moreillon
P
P
Baumgartner
J D
JD
Yersin
B
B
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D017291:Clarithromycin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008586:Meningitis, Pneumococcal / Q000139:chemically induced*; D010033:Otitis Media / Q000188:drug therapy*; D011008:Pneumococcal Infections / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy; D013296:Streptococcus pneumoniae / Q000187:drug effects
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D017291:Clarithromycin